Apogem Capital’s Marcus Corp MCS Stock Holding History

Apogem Capital’s Portfolio MCS Stock Details MCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,000	Closed	-$472K	–	69
2022 Q3	$472K	Buy	+34,000	New	+$547K	0.47%	69

Other funds holding MCS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCP

Searchlight Capital Partners New York $109M AUM 43.33% 1-Year Est. Return

CPM

Corre Partners Management New York $64.9M AUM 16.2% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Apogem Capital's MCS Position: Q4 2022 in Review

Apogem Capital sold out of Marcus Corp (MCS) in Q4 2022, closing a stake of 34,000 shares — an estimated $472K sold.

Apogem Capital first reported a position in MCS in Q3 2022 and held it in 1 quarter. The position peaked at $472K in Q3 2022. 144 funds tracked by Wall St. Rank hold MCS as of Q4 2022.

Apogem Capital reported no remaining Marcus Corp position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 34,000 Marcus Corp shares in Q4 2022, an estimated $472K.
Apogem Capital first reported a position in Marcus Corp in Q3 2022 and held it in 1 quarter.
Apogem Capital's Marcus Corp position peaked at $472K in Q3 2022.
144 funds tracked by Wall St. Rank held Marcus Corp as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.